DAB2IP and cancer: The loss of ATM is sufficient to restore the sensitivity of DAB2IP-silenced cancer cells to radiotherapy by delaying double‐strand break (DSB) repair kinetics and counteracting the activation of NF-κB and p38MAPK [37].